PAQ Therapeutics
Industry
- Pharmaceuticals
- Vaccines
- Biotechnology
See more in Biomedtracker
Latest on PAQ Therapeutics
Scrip
• By Joseph Haas
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AzurRx Will Take First Wave Name After
Scrip
• By Mandy Jackson
Amylyx Pharmaceuticals, Inc. announced Phase II/III results for AMX0035 in the treatment of amyotrophic lateral sclerosis (ALS) last year and hoped to obtain US Food and Drug Administration approval